FREE COMMUNICATION 25

10.45-12.15   G104-G105

 

Diabetes
  

Chairs: Jolanta MaƂyszko, Bialystok, Poland
             Ivan Rychlik, Prague, Czech Republic
 
FREE COMMUNICATIONS
 
TO022
IN VITRO GENERATED REGULATORY T-CELLS AND INSULIN SECRETING CELLS-A POTENTIAL
CELLULAR THERAPY FOR END STAGE RENAL FAILURE DIABETIC NEPHROPATHY
Shruti D Dave1, Aruna V Vanikar2, Hargovind L Trivedi2
1G. R. Doshi and K. M. Mehta Inst Kidney Diseases & Research Centre (IKDRC)- Dr. H.L. Trivedi, Ahmedabad, India, 2G. R. Doshi and K. M. Mehta Inst Kidney Diseases & Research Centre [IKDRC]- Dr. H.L. Trivedi Inst Transplantation Sciences, Ahmedabad, India
 
TO023
INHIBITION OF FACTOR XA WITH RIVAROXABAN AMELIORATES PROTEINURIA AND REDUCES
INFLAMMATORY CYTOKINES WITH DIMINISHED LOSS OF ENDOTHELIAL GLYCOCALYX
IN DIABETIC NEPHROPATHY
Anna Bertram, Nelli Shushakova, Joon Keun Park, Torsten Kirsch, Putri Andina Agustian, Jan Menne,
Haller Hermann MHH, Hannover, Germany
  
TO024
IMPACTS OF O-GLCNAC ON ENDOTHELIAL NITRIC OXIDE SYNTHASE IN DIABETIC NEPHROPATHY
Renata Gellai1,2, Judit Hodrea1,2, Lilla Lenart1,2, Sandor Koszegi1,2, Agota Ver2, N. F. Banki2, Laszlo Wagner2, Norbert Fulop3, Agnes Molnar1, Adam Vannay4, Attila J. Szabo2, Andrea Fekete1,2
1MTA-SE, Budapest, Hungary, 2Semmelweis Univ, Budapest, Hungary, 3Kaposi Mór Teaching Hosp,
Kaposvar, Hungary, 4MTA-SE Pediatrics and Nephrology Research Group, Budapest, Hungary
 
TO025
MODERATE-INTENSITY RESISTANCE EXERCISE TRAINING PROTECTS KIDNEY, BUT NOT SKELETAL
MUSCLE FROM DAMAGES PROMOTED BY DIABETES MELLITUS.
Kleiton Augusto Santos Silva1, Ralmony Alcântara Santos2, Marcelo Rocino Arlotti1, Luciana Jorge1, Rafael Silva Luiz1, Rodolfo Rosseto Rampaso1, Tatiana Sousa Cunha2, Nestor Schor1
1Federal Univ São Paulo, São Paulo, Brazil, 2Federal Univ São Paulo, São José dos Campos, Brazil
  
TO026
TLR4 LINKS PODOCYTES WITH THE INNATE IMMUNE SYSTEM TO MEDIATE GLOMERULAR INJURY
IN PATIENTS WITH TYPE 2 DIABETES AND MICROALBUMINURIA (MA)
Emanuele L Parodi1, Francesca Ansaldo1, Elisa Veziano1, Barbara Villaggio1, Mariano Mij2, Fabio Gianiorio1, Francesca Viazzi1, Daniela Verzola1, Giacomo Garibotto1 1Genoa Univ, Genoa, Italy, 2Imperia Hosp, Imperia, Italy
 
TO027
ROADMAP OBSERVATIONAL FOLLOW-UP STUDY: BENEFITS OF RAAS BLOCKADE WITH OLMESARTAN
TREATMENT ARE SUSTAINED AFTER STUDY DISCONTINUATION
Jan Menne1, Eberhard Ritz2, Luis M Ruilope3, Christos Chatzikyrkou1, Giancarlo Viberti4, Hermann
Haller1 1Medical School Hannover, Hannover, Germany, 2Univ Heidelberg, Heidelberg, Germany, 3Hosp 12 de Octubre, Madrid, Spain, 4King’s College London School of Medicine, London, UK
 
back to the timetable